• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Skye Bioscience, Inc. - Common Stock (NQ:SKYE)

    0.8782 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Jan 2, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 151,715
    Open 0.8782
    Bid (Size) 0.9250 (200)
    Ask (Size) 0.9390 (1,500)
    Prev. Close 0.8782
    Today's Range 0.8782 - 0.8782
    52wk Range 0.6844 - 5.750
    Shares Outstanding 417,247,333
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire

    Performance

    YTD
    N/A
    N/A
    1 Month
    -26.8%
    -26.8%
    3 Month
    -53.8%
    -53.8%
    6 Month
    -80.0%
    -80.0%
    1 Year
    -70.4%
    -70.4%

    More News

    Read More
    News headline image
    SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    NASDAQ: SKYE INVESTOR ALERT: Berger Montague Advises Skye Bioscience, Inc. (NASDAQ: SKYE) Investors of a January 16, 2026 Deadline
    From Berger Montague
    Via GlobeNewswire
    News headline image
    SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    Which stocks are moving after the closing bell on Tuesday? ↗
    Via Chartmill
    News headline image
    SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    SKYE SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    Bragar Eagel & Squire, P.C. Urges DeFi, Skye Bioscience, and Perrigo Investors to Contact the Firm Regarding their Rights
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    Berger Montague PC Investigating Claims on Behalf of Skye Bioscience, Inc. (NASDAQ: SKYE) Investors After Class Action Filing
    From Berger Montague
    Via GlobeNewswire
    News headline image
    ROSEN, LEADING INVESTOR COUNSEL, Encourages Skye Bioscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SKYE
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Skye Bioscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SKYE
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    Bragar Eagel & Squire, P.C. Urges DeFi, Skye Bioscience, and Perrigo Investors to Contact the Firm Regarding their Rights
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    SKYE INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Skye Bioscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SKYE
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    What One Fund's Sale of Centessa Stock Signals About the Fast-Rising Biotech Company ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Skye Bioscience and Perrigo and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire

    Frequently Asked Questions

    Is Skye Bioscience, Inc. - Common Stock publicly traded?
    Yes, Skye Bioscience, Inc. - Common Stock is publicly traded.
    What exchange does Skye Bioscience, Inc. - Common Stock trade on?
    Skye Bioscience, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Skye Bioscience, Inc. - Common Stock?
    The ticker symbol for Skye Bioscience, Inc. - Common Stock is SKYE on the Nasdaq Stock Market
    What is the current price of Skye Bioscience, Inc. - Common Stock?
    The current price of Skye Bioscience, Inc. - Common Stock is 0.8782
    When was Skye Bioscience, Inc. - Common Stock last traded?
    The last trade of Skye Bioscience, Inc. - Common Stock was at 01/02/26 04:00 PM ET
    What is the market capitalization of Skye Bioscience, Inc. - Common Stock?
    The market capitalization of Skye Bioscience, Inc. - Common Stock is 366.43M
    How many shares of Skye Bioscience, Inc. - Common Stock are outstanding?
    Skye Bioscience, Inc. - Common Stock has 366M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.